Research Paper Volume 16, Issue 3 pp 2679—2701
Underlying mechanisms of novel cuproptosis-related dihydrolipoamide branched-chain transacylase E2 (DBT) signature in sunitinib-resistant clear-cell renal cell carcinoma
Figure 7. Graphic abstract for executing this research project will provide insight into how cuproptosis affects the development of RCC and the molecular mechanism of drug resistance, and hopefully helps to develop novel therapeutic strategies to treat drug-resistant renal cell carcinoma.